182 related articles for article (PubMed ID: 10689145)
21. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence.
Effros RB; Boucher N; Porter V; Zhu X; Spaulding C; Walford RL; Kronenberg M; Cohen D; Schächter F
Exp Gerontol; 1994; 29(6):601-9. PubMed ID: 9435913
[TBL] [Abstract][Full Text] [Related]
22. In vitro senescence models for human T lymphocytes.
Pawelec G; Adibzadeh M; Rehbein A; Hähnel K; Wagner W; Engel A
Vaccine; 2000 Feb; 18(16):1666-74. PubMed ID: 10689146
[TBL] [Abstract][Full Text] [Related]
23. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
24. The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation.
Plunkett FJ; Franzese O; Finney HM; Fletcher JM; Belaramani LL; Salmon M; Dokal I; Webster D; Lawson AD; Akbar AN
J Immunol; 2007 Jun; 178(12):7710-9. PubMed ID: 17548608
[TBL] [Abstract][Full Text] [Related]
25. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells.
Henson SM; Franzese O; Macaulay R; Libri V; Azevedo RI; Kiani-Alikhan S; Plunkett FJ; Masters JE; Jackson S; Griffiths SJ; Pircher HP; Soares MV; Akbar AN
Blood; 2009 Jun; 113(26):6619-28. PubMed ID: 19406987
[TBL] [Abstract][Full Text] [Related]
26. The Maintenance of Telomere Length in CD28+ T Cells During T Lymphocyte Stimulation.
Huang EE; Tedone E; O'Hara R; Cornelius C; Lai TP; Ludlow A; Wright WE; Shay JW
Sci Rep; 2017 Jul; 7(1):6785. PubMed ID: 28754961
[TBL] [Abstract][Full Text] [Related]
27. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
Zheng X; Gao JX; Chang X; Wang Y; Liu Y; Wen J; Zhang H; Zhang J; Liu Y; Zheng P
J Immunol; 2004 Aug; 173(4):2253-61. PubMed ID: 15294937
[TBL] [Abstract][Full Text] [Related]
28. CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
Leitner J; Herndler-Brandstetter D; Zlabinger GJ; Grubeck-Loebenstein B; Steinberger P
J Immunol; 2015 Jul; 195(2):477-87. PubMed ID: 26041540
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription.
Lewis DE; Merched-Sauvage M; Goronzy JJ; Weyand CM; Vallejo AN
J Biol Chem; 2004 Jul; 279(28):29130-8. PubMed ID: 15128741
[TBL] [Abstract][Full Text] [Related]
30. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
31. Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells.
Speiser DE; Migliaccio M; Pittet MJ; Valmori D; Liénard D; Lejeune F; Reichenbach P; Guillaume P; Lüscher I; Cerottini JC; Romero P
Eur J Immunol; 2001 Feb; 31(2):459-66. PubMed ID: 11180110
[TBL] [Abstract][Full Text] [Related]
32. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
33. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L; Clark EA; Shu G; Dupont B
J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
[TBL] [Abstract][Full Text] [Related]
34. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475
[TBL] [Abstract][Full Text] [Related]
35. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
Sepulveda H; Cerwenka A; Morgan T; Dutton RW
J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
[TBL] [Abstract][Full Text] [Related]
36. Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.
Fröhlich M; Gogishvili T; Langenhorst D; Lühder F; Hünig T
Eur J Immunol; 2016 Jul; 46(7):1644-55. PubMed ID: 27122236
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells.
Ronchetti S; Nocentini G; Bianchini R; Krausz LT; Migliorati G; Riccardi C
J Immunol; 2007 Nov; 179(9):5916-26. PubMed ID: 17947665
[TBL] [Abstract][Full Text] [Related]
38. Proliferation of CD8+ in culture of human T cells derived from peripheral blood of adult donors and cord blood of newborns.
Brzezińska A; Magalska A; Sikora E
Mech Ageing Dev; 2003 Apr; 124(4):379-87. PubMed ID: 12714243
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
40. Functional properties of CD4+ CD28- T cells in the aging immune system.
Weyand CM; Brandes JC; Schmidt D; Fulbright JW; Goronzy JJ
Mech Ageing Dev; 1998 May; 102(2-3):131-47. PubMed ID: 9720647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
